Eli Lilly’s weight loss med tirzepatide gets endorsement from U.K.’s NICE

by
Contributor since / Followers
19 hours ago
Two dosing pens of a fictitious semaglutide drug (GLP-1) on a scale facing a dumbbell. Concept for alternative ways to loose weight.

aprott/iStock via Getty Images

  • The U.K.’s drug cost-effectiveness watchdog organization, the National Institute for Health and Care Excellence (“NICE”), has formally recommended Eli Lilly’s (NYSE:LLY) GLP-1 tirzepatide as a treatment for weight loss.
  • The drug is sold under the name Zepbound for weight loss
Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *